By Counterforce Health Team in Fabrazyme (agalsidase beta) —

Lowering Out-of-Pocket Costs for Fabrazyme (Agalsidase Beta) with Cigna in Pennsylvania: Complete Coverage and Savings Guide

Answer Box: Getting Fabrazyme Covered by Cigna in Pennsylvania

Fabrazyme (agalsidase beta) requires prior authorization with Cigna in Pennsylvania and is typically placed in a high specialty tier (Tier 4-5). To get coverage: (1) Have your specialist submit electronic PA through CoverMyMeds or ExpressPAth with genetic/biochemical confirmation of Fabry disease, (2) Apply for Sanofi's CareConnectPSS copay assistance if you have commercial insurance, and (3) Use Pennsylvania's new external review program if initially denied—about 50% of external appeals succeed. Start by calling Cigna member services to confirm your formulary tier and PA requirements today.

Table of Contents

  1. What Drives Your Fabrazyme Costs
  2. Investigating Your Cigna Benefits
  3. Copay Assistance and Financial Support
  4. Requesting Formulary Exceptions
  5. Choosing the Right Pharmacy
  6. Appeals Process in Pennsylvania
  7. Annual Planning and Renewals
  8. Scripts for Key Conversations

What Drives Your Fabrazyme Costs

Understanding how Cigna structures specialty drug costs helps you navigate the system more effectively. Fabrazyme sits in the highest cost tier because it's a rare disease therapy with significant per-dose expenses—around $1,100 for a 5-mg vial and $7,600 for a 35-mg vial.

Benefit Design Basics

Your out-of-pocket costs depend on several factors:

  • Formulary tier placement: Fabrazyme typically lands in Tier 4 or 5, requiring coinsurance (a percentage) rather than flat copays
  • Prior authorization: Required for all Cigna plans, adding administrative steps but not direct costs
  • Step therapy: May require trying preferred alternatives first, though exceptions exist for medical necessity
  • Quantity limits: Based on weight-based dosing (1 mg/kg every 2 weeks)

Specialty vs. Medical Benefit

Fabrazyme can be covered under either your pharmacy benefit (if self-administered) or medical benefit (if infused in a clinical setting). Medical benefit coverage often has different cost-sharing rules and may result in lower out-of-pocket expenses for some patients.

Tip: Ask your provider about both administration options—home infusion through specialty pharmacy versus clinic infusion—as costs can vary significantly.

Investigating Your Cigna Benefits

Before starting treatment, gather specific information about your coverage to avoid surprises.

Essential Questions for Cigna Member Services

Call the number on your insurance card and ask:

  1. Formulary status: "Is Fabrazyme covered on my plan's formulary, and what tier is it in?"
  2. Prior authorization: "What's required for PA approval, and how long does it take?"
  3. Cost-sharing: "What's my coinsurance percentage for specialty tier medications?"
  4. Annual limits: "Do I have an out-of-pocket maximum that includes specialty drugs?"
  5. Pharmacy network: "Must I use Accredo, or are other specialty pharmacies covered?"

Information to Record

Document these details from your call:

  • Representative name and reference number
  • Exact tier placement and coinsurance percentage
  • PA requirements and submission process
  • Specialty pharmacy requirements
  • Appeals process and deadlines

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Electronic submission required with diagnosis confirmation CoverMyMeds, ExpressPAth, or provider portal Cigna PA Policy
Specialty Tier Typically Tier 4-5 with coinsurance vs. flat copay Member portal or Summary of Benefits Cigna Formulary
Accredo Requirement Must use Cigna's specialty pharmacy for most plans Plan documents or member services Accredo Information
Medical Necessity Confirmed Fabry disease diagnosis required Provider documentation and genetic testing Coverage Criteria

Copay Assistance and Financial Support

Multiple programs can significantly reduce your out-of-pocket costs, but eligibility varies by insurance type.

Manufacturer Support: Sanofi CareConnectPSS

If you have commercial insurance (not Medicare/Medicaid), Sanofi's copay assistance program covers 100% of eligible out-of-pocket drug costs for Fabrazyme.

Eligibility Requirements:

  • Commercial insurance coverage
  • U.S. residency
  • No income limits
  • Not covered by government programs (Medicare, Medicaid, VA, TRICARE)

What's Covered:

  • Drug copays and coinsurance
  • Certain infusion-related costs (mixing, administration supplies)
  • Not covered: Office visits, nursing services, lab tests, transportation
Note: Massachusetts and Rhode Island residents cannot receive infusion-related cost coverage due to state regulations.

Application Process: Work with your prescribing physician to enroll through the Fabrazyme support website. No income documentation is required for commercial insurance patients.

Foundation Support for Government Insurance

If you have Medicare, Medicaid, or other government coverage, consider these nonprofit options:

  • Patient Access Network Foundation: Income limits typically 300-400% of Federal Poverty Level
  • HealthWell Foundation: Disease-specific funds with income requirements
  • Patient Advocate Foundation: Co-pay relief and case management services

Each foundation has different eligibility criteria and funding availability, so apply to multiple programs if eligible.

Requesting Formulary Exceptions

When Fabrazyme isn't covered or faces significant restrictions, formulary exceptions can provide a path to coverage.

When to Request Exceptions

Consider a formulary exception if:

  • Fabrazyme is non-formulary on your plan
  • Step therapy requirements don't fit your clinical situation
  • Quantity limits are insufficient for proper dosing
  • Preferred alternatives have failed or are contraindicated

Required Documentation

Your provider must submit:

  • Medical necessity letter detailing why Fabrazyme is essential
  • Confirmed Fabry disease diagnosis via genetic or biochemical testing
  • Prior therapy documentation showing failure, intolerance, or contraindications to alternatives
  • Clinical notes from the past 90 days supporting the request
  • Patient weight for dosing calculations
  • Specialist involvement from genetics, nephrology, cardiology, or neurology

Submission Process

Exceptions follow the same electronic submission process as prior authorization:

  1. Provider submits through CoverMyMeds, ExpressPAth, or Cigna portal
  2. Include all supporting documentation upfront
  3. Standard review takes 5 business days
  4. Expedited review available for urgent cases

Choosing the Right Pharmacy

Pharmacy selection affects both convenience and costs, especially for specialty medications like Fabrazyme.

Accredo: Cigna's Preferred Specialty Pharmacy

Most Cigna plans require Accredo for specialty medications, offering:

  • Coordination benefits: Streamlined PA processing and appeals support
  • Clinical support: 24/7 access to pharmacists and nurses familiar with Fabrazyme
  • Logistics: Temperature-controlled shipping and administration supplies
  • Financial assistance: Help coordinating manufacturer copay programs

Alternative Options

Some plans may allow other specialty pharmacies, but verify coverage levels:

  • Network specialty pharmacies: May have different cost-sharing
  • Hospital-based pharmacies: For clinic-administered infusions
  • Home infusion services: If your plan covers home administration

Coordination Tips

  • Confirm your pharmacy is in-network before filling prescriptions
  • Ask about financial assistance program coordination
  • Verify they can handle temperature-sensitive medications
  • Ensure they provide necessary administration supplies
From Our Advocates: "We've seen patients save thousands by confirming their specialty pharmacy coordinates manufacturer assistance before the first fill. One family discovered their pharmacy wasn't enrolled in the copay program, leading to a $3,000 surprise bill that took months to resolve."

Appeals Process in Pennsylvania

Pennsylvania has strengthened its appeals system, giving consumers better tools to fight denials.

Internal Appeals with Cigna

Timeline: 180 days from denial to file Process:

  1. Request complete denial letter with specific reasons
  2. Gather additional clinical documentation addressing denial reasons
  3. Submit appeal through member portal or by mail/fax
  4. Include updated medical necessity letter from provider
  5. Expect decision within 30 days (15 for expedited)

Pennsylvania External Review Program

If internal appeals fail, Pennsylvania's Independent External Review Program offers strong consumer protections launched in 2024.

Key Statistics: In the program's first year, about 50% of appealed denials were overturned, resulting in coverage for treatments initially denied.

Eligibility:

  • Must complete Cigna's internal appeal process first
  • Receive Final Adverse Benefit Determination letter
  • File within 4 months of final denial

Process:

  1. Submit request online via Pennsylvania Insurance Department website or by mail/fax
  2. Independent Review Organization (IRO) assigned within days
  3. Submit additional supporting information within 15 days
  4. Standard reviews decided within 45 days
  5. Expedited reviews for urgent cases decided within 72 hours

Required Documentation:

  • Final denial letter from Cigna
  • All medical records supporting medical necessity
  • Provider statement explaining why Fabrazyme is essential
  • Any additional clinical evidence (research, guidelines)
Tip: Pennsylvania's external review program is binding on insurers—if the IRO rules in your favor, Cigna must provide coverage, including retroactive coverage if you paid out-of-pocket.

Annual Planning and Renewals

Specialty drug coverage can change annually, requiring proactive planning.

What Changes Each Year

  • Formulary placement: Drugs can move tiers or become non-formulary
  • Prior authorization requirements: Criteria may become more restrictive
  • Specialty pharmacy networks: Preferred pharmacies can change
  • Cost-sharing: Coinsurance percentages and out-of-pocket maximums adjust

Planning Checklist (October-November)

  • Review next year's formulary for Fabrazyme placement
  • Confirm continued Accredo network participation
  • Check if PA requirements have changed
  • Verify continued eligibility for assistance programs
  • Calculate projected annual costs under new benefits

Renewal Strategy

If changes negatively affect your coverage:

  • Request formulary exception before January 1st
  • Consider alternative plan options during open enrollment
  • Apply for foundation grants early in the year when funding is available
  • Coordinate with Counterforce Health for complex appeals assistance

Scripts for Key Conversations

Having the right language ready streamlines important conversations about coverage.

Calling Cigna Member Services

"Hi, I need to verify coverage for Fabrazyme, spelled F-A-B-R-A-Z-Y-M-E, for Fabry disease. Can you tell me: Is it covered on my formulary? What tier? Is prior authorization required? What's my coinsurance for specialty medications? Do I need to use Accredo pharmacy?"

Provider Office: Requesting PA Support

"I need help with prior authorization for Fabrazyme. Can you submit through CoverMyMeds or ExpressPAth? I'll need documentation of my Fabry disease diagnosis, prior treatments if any, and a medical necessity letter. The genetic testing results should be included."

Accredo Coordination Call

"I'm starting Fabrazyme and want to coordinate manufacturer copay assistance. Can you help enroll me in Sanofi's CareConnectPSS program? I also need to understand the delivery schedule and what supplies are included."

Appeal Support Request

"My Fabrazyme prior authorization was denied. I need help filing an internal appeal. Can you provide additional clinical documentation addressing the denial reasons? I may need this to escalate to Pennsylvania's external review program."

Counterforce Health specializes in turning insurance denials into successful appeals through targeted, evidence-backed strategies. Our platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and appeals processes for medications like Fabrazyme. By analyzing denial letters, plan policies, and clinical notes, we identify the specific issues blocking coverage and draft comprehensive rebuttals aligned with each plan's requirements. Visit www.counterforcehealth.org to learn how our approach can help secure coverage for essential treatments.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and requirements may vary by plan and change over time. Always verify current information with your insurance provider and consult healthcare professionals for medical decisions. For personalized assistance with complex appeals, consider working with coverage advocates like Counterforce Health who specialize in rare disease medication access.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.